4
Changes in Ownership
Milestone Pharmaceuticals Inc. Filed Acc 0001415889-25-002268
Options or other derivatives
- Chief Commercial Officer acquired 201,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Muller Lorenz Chief Commercial Officer | 2025-01-27 | Grant or award · Employee Stock Option (right to buy) | +120,600 | 120,600 | D | ||
| Muller Lorenz Chief Commercial Officer | 2025-01-27 | Grant or award · Restricted Stock Unit | +80,400 | 80,400 | D | ||
Loading xslF345X05/form4-01292025_040111.xml…